Molecular Insights into miRNA-Driven Resistance to 5-Fluorouracil and Oxaliplatin Chemotherapy: miR-23b Modulates the Epithelial–Mesenchymal Transition of Colorectal Cancer Cells

• Published in: Journal of clinical medicine Vol. 8; no. 12; p. 2115
• Main Authors: Gasiulė, Stasė, Dreize, Nadezda, Kaupinis, Algirdas, Ražanskas, Raimundas, Čiupas, Laurynas, Stankevičius, Vaidotas, Kapustina, Žana, Laurinavičius, Arvydas, Valius, Mindaugas, Vilkaitis, Giedrius
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 02.12.2019
• Subjects: 5-fluorouracil; epithelial–mesenchymal transition; chemoresistance; miRNome; microRNA; oxaliplatin; drug resistance; proteome
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm8122115

Although treatment of colorectal cancer with 5-florouracil and oxaliplatin is widely used, it is frequently followed by a relapse. Therefore, there is an urgent need for profound understanding of chemotherapy resistance mechanisms as well as the profiling of predictive markers for individualized treatment. In this study, we identified the changes in 14 miRNAs in 5-fluouracil and 40 miRNAs in oxaliplatin-resistant cell lines by miRNA sequencing. The decrease in miR-224-5p expression in the 5-fluorouracil-resistant cells correlated with drug insensitivity due to its overexpression-induced drug-dependent apoptosis. On the other hand, the miR-23b/27b/24-1 cluster was overexpressed in oxaliplatin-resistant cells. The knockout of miR-23b led to the partial restoration of oxaliplatin susceptibility, showing the essential role of miR-23b in the development of drug resistance by this cluster. Proteomic analysis identified target genes of miR-23b and showed that endothelial-mesenchymal transition (EMT) was implicated in oxaliplatin insensibility. Data revealed that EMT markers, such as vimentin and SNAI2, were expressed moderately higher in the oxaliplatin-resistant cells and their expression increased further in the less drug-resistant cells, which had miR-23b knockout. This establishes that the balance of EMT contributes to the drug resistance, showing the importance of the miR-23b-mediated fine-tuning of EMT in oxaliplatin-resistant cancer cells.